CRNX vs STZ · rev $7.7M vs P/E 14, rev $9.14B
Crinetics Pharmaceuticals Inc (CRNX) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. CRNX currently screens at market cap $2.76B.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
CRNX currently screens at market cap $2.76B. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the CRNX and STZ stock pages for the full models.
Not investment advice.